ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization

M. Singh, S. Anwar, D. Brennan, R. Delos Santos.

Internal Medicine/Nephrology, Washington University School of Medicine, St. Louis, MO.

Meeting: 2015 American Transplant Congress

Abstract number: C67

Keywords: Dosage, Graft function, Kidney transplantation

Session Information

Session Name: Poster Session C: Immunosuppression/Compliance

Session Type: Poster Session

Date: Monday, May 4, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Background: Multiple assays are available for measuring tacrolimus (FK) levels and these are not currently standardized. A designated laboratory transitioned their FK assay from Enzyme Multiplied Immunoassay Technique (EMIT) to Liquid Chromatography with Tandem Mass Spectrometry (LC-MSMS) during April and May 2013.

Methods: We analyzed the data on 393 patients transplanted between Jan 1993 and Dec 2012 from this designated laboratory who were on a stable dose of FK. The values of FK levels between January 2013 and August 2013 (3 months before and after the assay change) were also analyzed for these patients for comparison. Continuous variables are described as means with SD. The proportion of patients requiring dose change was described as a percentage. Paired T-tests were used to compare the mean FK level before and after the assay change.

Results: The table shows the results of the paired t-tests. There was a significant difference in the mean FK levels before and after the change in assay. After the adjustment in FK dose, there was no significant difference in the mean FK levels.

Table 1
Pairs Mean Standard Deviation P-value
1) Month 1 5.93 1.71 0.075
1) Month 3 5.65 1.86  
2) Month 1 5.95 2.14 <0.001
2) Month 4 5.33 1.65  
3) Month 1 5.90 2.16 <0.001
3) Month 5 3.76 1.57  
4) Month 5 3.77 1.76 0.297
4) Month 7 3.63 1.58  
5) Month 5 3.86 1.76 0.154
5) Month 8 3.61 1.73  
       
Age 53.95 14.92  
Required dose change 60 (15.3%)    

Conclusion: This study highlights the importance of the type of Tacrolimus assay on the FK levels and urgent need for standardization. The implementation of liquid chromatography with tandem mass spectrometry (LC-MSMS) technique as a standard could help standardize the reporting of FK levels. There is an urgent need to develop best practice guidelines for LC-MSMS methods for its use for routine FK measurement. This will help harmonize results across the diagnostic laboratories.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Singh M, Anwar S, Brennan D, Santos RDelos. Impact of Type of Tacrolimus Assay on Therapeutic Drug Monitoring: Need for Standardization [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-type-of-tacrolimus-assay-on-therapeutic-drug-monitoring-need-for-standardization/. Accessed May 12, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences